Search for: "Eli Lilly "
Results 221 - 240
of 2,147
Sort by Relevance
|
Sort by Date
4 Mar 2020, 6:02 am
The post Eli Lilly Secretly Paid Millions to Secure Favorable Verdict in Mass Shooting Lawsuit appeared first on pissd.com. [read post]
4 Mar 2020, 6:02 am
The post Eli Lilly Secretly Paid Millions to Secure Favorable Verdict in Mass Shooting Lawsuit appeared first on pissd.com. [read post]
27 Feb 2020, 8:21 am
Eli Lilly and Company, SCT Docket No. [read post]
26 Feb 2020, 2:58 am
Taltz is Eli Lilly's marketed anti-IL-17A/F monoclonal antibody ixekizumab. [read post]
23 Feb 2020, 4:31 am
Eli Lilly & Co.'s factory in Indianapolis in 1862 Author Eli Lilly & Co. [read post]
19 Feb 2020, 3:25 am
And Canada (Source: GM Authority) Jeremy Horwitz: Apple Seeks to Patent Machine Learning Correction of GPS Estimates (Source: The Verge) Source: USPTO Commentary and Journal Articles: Noel Courage: Patenting Coronavirus Treatments (Source: Lexology) Hristina Georgieva: Legal Protection of Video Games (Source: SSRN) Léon Dijkman: Changing Business Models: Huawei Makes a Surprising Announcement, or, The Changing Role of Patents in the Global Economy (Source: SSRN) New Job… [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan Pharmaceuticals ULC v Eli Lilly… [read post]
6 Feb 2020, 12:43 pm
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company (“Lilly”) of Indianapolis, Indiana, filed suit in the Southern District of Indiana seeking a declaratory judgment that Lilly did not misappropriate any trade secrets of Defendant, SensorRx, Inc. [read post]
29 Jan 2020, 12:34 am
Finally, this part of the book discusses the impact of the ruling in Regents of the University of California v Eli Lilly & Co and how this case has influenced the application of the written description requirement in the US. [read post]
7 Jan 2020, 7:26 am
Had the patent been valid, it would have been infringed. (3) Plausibility and SPC's The Eli Lilly v Genentech proceedings do not only relate to a (typical) patent revocation/infringement action, but also involved an issue on third-party SPC applications. [read post]
19 Dec 2019, 9:41 am
In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
4 Dec 2019, 7:57 am
Brian Corderyby Selina Badiani The leading Supreme Court case of Actavis v Eli Lilly [2017] UKSC 48 introduced a doctrine of equivalents into UK patent law for the first time in many years. [read post]
28 Nov 2019, 12:57 pm
In reply to the appeal, Eli Lilly has argued that it was incorrect for the EPO to apply the co-applicant to the patent. [read post]
22 Nov 2019, 2:56 pm
., 920 F.3d 958, 964 (5th Cir. 2019); Eli Lilly & Co. v.Hospira, Inc., 933 F.3d 1320, 1327 (Fed. [read post]
22 Nov 2019, 10:32 am
Eli Lilly and Co. v. [read post]
1 Nov 2019, 6:45 am
” Drugmakers Merck, Eli Lilly and Amgen challenged the rules in a lawsuit. [read post]
8 Oct 2019, 9:44 am
”) Eli Lilly and Company v. [read post]
2 Oct 2019, 6:11 am
” Drugmakers Amgen, Merck, and Eli Lilly “teamed up with the Association of National Advertisers to challenge the rule making drugmakers put list prices in ads” in a lawsuit “filed Friday in federal court against the Department of Health and Human Services and the Centers for Medicare and Medicaid Services. [read post]
23 Sep 2019, 9:24 am
Eli Lilly and Company v. [read post]
16 Sep 2019, 2:10 am
The referral, but unfortunately not the referred question, has now been answered by the CJEU with its order in Eli Lilly v. [read post]
